STIM
Neuronetics Inc.
Company Overview
| Mkt Cap | $177.38M | Price | $1.52 |
| Volume | 1.89M | Change | -4.11% |
| P/E Ratio | -4.1 | Open | $1.69 |
| Revenue | $74.9M | Prev Close | $1.58 |
| Net Income | $-43.7M | 52W Range | $0.80 - $4.85 |
| Div Yield | N/A | Target | $4.33 |
| Overall | 37 | Value | 45 |
| Quality | 28 | Technical | 40 |
No chart data available
About Neuronetics Inc.
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Latest News
Neuronetics (STIM) Receives a Buy from Piper Sandler
Wall Street Analysts Are Bullish on Top Healthcare Picks
Neuronetics Appoints New CEO to Lead Next Growth Phase
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STIM | $1.52 | -4.1% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |